Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Gomez

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Chronic Diseases and Translational Medicine|May 15, 2018
Functional promoter rs189037 variant of <i>ATM</i> is associated with decrease in lung diffusing capacity after irradiation for non-small-cell lung cancerJose Luis Lopez Guerra, Yi-Peng Song, Quynh-Nhu Nguyen, et al.
Chronic Diseases and Translational Medicine|July 11, 2018
DNA repair capacity correlates with standardized uptake values from <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non-small-cell lung cancerXin Eric Jiang, Ting Xu, Qingyi Wei, et al.
JAMA Network Open|June 15, 2026
Futile Radiotherapy for Patients With Cancer Near the End of LifeAlok Deshane, Morgan Freret, Victoria S Brennan, et al.
Practical Radiation Oncology|April 22, 2017
Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancerPenny Fang, Cameron W Swanick, Todd A Pezzi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerMatthew S Ning, Linglong Tang, Daniel R Gomez, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2017
Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation TherapyRongRong Zhou, Ting Xu, Quynh-Nhu Nguyen, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2016
Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective DatabaseAndreas Rimner, Xiaopan Yao, James Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung CarcinomaKeeratikarn Boonyawan, Daniel R Gomez, Ritsuko Komaki, et al.
Physics in Medicine and Biology|March 14, 2012
Spatial correspondence of 4D CT ventilation and SPECT pulmonary perfusion defects in patients with malignant airway stenosisRichard Castillo, Edward Castillo, Matthew McCurdy, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Chronic Diseases and Translational Medicine|May 15, 2018
Functional promoter rs189037 variant of <i>ATM</i> is associated with decrease in lung diffusing capacity after irradiation for non-small-cell lung cancerJose Luis Lopez Guerra, Yi-Peng Song, Quynh-Nhu Nguyen, et al.
Chronic Diseases and Translational Medicine|July 11, 2018
DNA repair capacity correlates with standardized uptake values from <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non-small-cell lung cancerXin Eric Jiang, Ting Xu, Qingyi Wei, et al.
JAMA Network Open|June 15, 2026
Futile Radiotherapy for Patients With Cancer Near the End of LifeAlok Deshane, Morgan Freret, Victoria S Brennan, et al.
Practical Radiation Oncology|April 22, 2017
Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancerPenny Fang, Cameron W Swanick, Todd A Pezzi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerMatthew S Ning, Linglong Tang, Daniel R Gomez, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2017
Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation TherapyRongRong Zhou, Ting Xu, Quynh-Nhu Nguyen, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2016
Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective DatabaseAndreas Rimner, Xiaopan Yao, James Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung CarcinomaKeeratikarn Boonyawan, Daniel R Gomez, Ritsuko Komaki, et al.
Physics in Medicine and Biology|March 14, 2012
Spatial correspondence of 4D CT ventilation and SPECT pulmonary perfusion defects in patients with malignant airway stenosisRichard Castillo, Edward Castillo, Matthew McCurdy, et al.
Pageof 24